Transient congenital hypothyroidism due to maternal factor

Summary

Transient congenital hypothyroidism due to maternal factor (MONDO:0016555) is a disease. A subtype of transient congenital hypothyroidism — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	transient congenital hypothyroidism due to maternal factor
Mondo ID	MONDO:0016555
Orphanet	238696
UMLS	C5680929
MedGen	1842783
GARD	0020645
Is cancer (heuristic)	no

Disease family

This is a subtype of transient congenital hypothyroidism. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › endocrine system disorder › thyroid gland disorder › hypothyroidism › congenital hypothyroidism › transient congenital hypothyroidism › transient congenital hypothyroidism due to maternal factor

Related subtypes (1): transient congenital hypothyroidism due to neonatal factor

Subtypes (3): fetal iodine syndrome, congenital hypothyroidism due to maternal intake of antithyroid drugs, congenital hypothyroidism due to transplacental passage of maternal TSH-binding inhibitory antibodies

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.